Keratin 16 expression in epidermal melanocytes of normal human skin

American Journal of Dermatopathology

Volumn 27, Issue 6, 2005, Pages 476-481

  Bhawan, Jag ^a   Whren, Kara ^a   Panova, Izabela ^a   Yaar, Mina ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Keratin; Melanocytes; Skin

Indexed keywords

KEARTIN 16; KERATIN; PROTEIN S 100; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOSKELETON; EPIDERMIS CELL; EPITHELIUM CELL; FEMALE; FIBROBLAST; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; TISSUE CULTURE; WESTERN BLOTTING; AGED; BIOSYNTHESIS; EPIDERMIS; METABOLISM; MIDDLE AGED; NEWBORN;

ADULT; AGED; BLOTTING, WESTERN; CELLS, CULTURED; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; KERATINS; MALE; MELANOCYTES; MIDDLE AGED;

EID: 33644820251     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000179627.81172.37     Document Type: Article

References (37)

1. Wawersik MJ, Mazzalupo S, Nguyen D, et al. Increased levels of keratin 16 alter epithelialization potential of mouse skin keratinocytes in vivo and ex vivo. Mol Biol Cell. 2001;12:3439-3450.
2. Machesney M, Tidman N,Wassem A, et al. Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol. 1998;152:1133-1141.
3. Stoler A, Duvic M, Fuch M. Unusual patterns of keratin expression in the overlying epidermis of patients with dermatofibromas: biochemical alterations in epidermis as a consequence of dermal tumors. J Invest Dermatol. 1989;93:728-737.
4. Swensson O, Langbein L, McMillan JR, et al. Specialized keratin expression pattern in human ridged skin as an adaption to high physical stress. Br J Dermatol. 1998;139:767-775.
5. Stoler A, Kopan R, Duvic M, et al. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol. 1988;107: 427-446.
6. Miettinem M, Franssila M. Immunohistochemical spectrum of malignant melanoma: the common presence of keratins. Lab Invest. 1989;61:623-628.
7. Gatter KC, Ralfkiaer E, Skinner J, et al. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumors. J Clin Pathol. 1985;38:1353.
8. Fuchs U, Tero K, Summanen P, et al. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol. 1992;141:169-181.
9. Zarbo RJ, Gown AM, Nagle RB, et al. Anomalous cytokeratin expression in malignant melanoma: one and two dimensional western blot analysis and immunohistochemical survey of 100 melanoma. Mod Pathol. 1990;3:494-501.
10. Katagata Y, Kondo S. Keratin expression and its significance in five cultured melanoma cell lines derived from primary, recurrent and metastasized melanomas. FEBS Lett. 1997;407:25-31.
11. Trejdosiewicz LK, Southgage J, Kemshead JT, et al. Phenotypic analysis of cultured melanoma cells: expression of cytokeratin-type intermediate filaments by the M5 human melanoma cell line. Exp Cell Res. 1986;164:388-398.
12. Churg A. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol. 1985;9:360-365.
13. Meis JM, Ordonez NG, Bruner JM. Meningiomas: an immunohistochemical study of 50 cases. Arch Pathol Lab Med. 1986;110:934-937.
14. Salisbury JR, Issacson PG. Demonstration of cytokeratins and an epithelial membrane antigens in chordomas and human fetal notochord. Am J Surg Pathol. 1985;9:791-797.
15. Manivel JC, Wick MR, Dehner LP, et al. Epithelioid sarcoma: an immunohistochemical study. Am J Clin Pathol. 1991;61:81-87.
16. Katagata Y, Aoki T, Kawa Y, et al. Keratin subunit expression in human cultured melanocytes and mouse neural crest cells without formation of filamentous structures. J Invest Dermatol. 1999;4:110-115.
17. Leigh I, Navsaria H, Purkis P, et al. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol. 1995;133:501-511.
18. Gilchrest BA, Albert LS, Karassik RL, et al. Substrate influences human epidermal melanocyte attachment and spreading in vitro. In Vitro Cell Dev Biol. 1985;21:114-120.
19. Gilchrest B. A relationship between actinic damage and chronologic aging in keratinocyte cultures of human skin. J Invest Dermatol. 1979;72:219-223.
20. Verdier-Sevrain S, Yaar M, Cantatore J, et al. Estradiol induces proliferation of keratinocytes via a receptor-mediated mechanism. FASEB J. 2004;18:1252-1254.
21. Bhawan J, Bansal C, Whren K, et al. K16 Expression in uninvolved psoriatic skin; a possible marker of pre-clinical psoriasis. J Cutan Pathol. 2004;31:471-476.
22. Esgleyes-Ribot T, Chandraratma RA, Lew-Kaya DA, et al. Response of psoriasis to a new topical retinoid. J Am Acad Dermatol. 1994;30: 581-590.
23. Hughes BR, Morris C, Cunliffe WJ, et al. Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol. 1996;134:247-256.
24. Ong'uti MN, Howells GL,Williams DM. An immunohistochemical study of keratin expression in ameloblastoma from Kenyan population. Oral Dis. 1999;5:111-116.
25. Castelijins FA, GerritsenMJ, van Vlijmen-Willems IM, et al. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis. J Am Acad Dermatol. 1999;40:901-909.
26. Huitfeld HS, Brandzaeg P. Various keratin antibodies produce immunohistochemical staining of human mycocardum and myometrium. Histochemistry. 1985;83:381-389.
27. Brown DC, Theaker JM, Banks PM, et al. Cytokeratin expression smooth muscle and smooth muscle tumors. Hisopathology. 1987;11:477-486.
28. Norton AJ, Thomas JA, Issacson PG. Cytokeratin-specific monoclonal antibodies are reactive with tumors of smooth muscle derivation: an immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal protein. Histopathology. 1987;11:487-499.
29. Gown AM, Boyd HC, Chang Y, et al. Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol. 1988;132:223-232.
30. Katagata Y, Takeda H, Ishizawa T, et al. Occurrence and comparison of the expressed keratins in cultured human fibroblasts, endothelial cells and their sarcomas. J Dermatol Sci. 2002;30:1-9.
31. Leader M, Patal J, Collins M, et al. Synovial sarcomas: true carcinosarcomas. Cancer. 1987;59:2096-2098.
32. Sewell HF, Thompson WD, King DJ. IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin. Br J Cancer. 1986;53:695-696.
33. Om A, Ghose T, Rowden G. Keratin and carcinoembryonic antigen (CEA) in human melanoma cells. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61:81-87.
34. Bhawan J. Mel-5 - a novel antibody in the differential diagnosis of pigmented lesions of the skin. Melanoma Res. 1994;4:21.
35. Min K, Hey Seung L, Han-Kwan Y, et al. Cytokeratin expression profile in gastric carcinomas. Hum Pathol. 2003;35:576-581.
36. Chang YT, Liu HN, Wang WJ, et al. A study of cytokeratin profiles in localized cutaneous amyloids. Arch Dermatol Res. 2004;296:83-88.
37. Wawersik M, Coulombe PA. Forced expression of keratin 16 alters the adhesion, differentiation, and migration of mouse skin keratinocytes. Mol Biol Cell. 2000;11:3315-3327.